156 related articles for article (PubMed ID: 1819726)
1. Effects of PAF antagonists on renal vascular escape and tachyphylaxis in perfused rabbit kidney.
Ferreira MG; Braquet P; Fonteles MC
Lipids; 1991 Dec; 26(12):1329-32. PubMed ID: 1819726
[TBL] [Abstract][Full Text] [Related]
2. Different classes of PAF-antagonists block norepinephrine-induced vascular escape and tachyphylaxis in the isolated rabbit kidney.
Ferreira MG; Fonteles MC
Res Commun Mol Pathol Pharmacol; 1996 Nov; 94(2):147-55. PubMed ID: 8987112
[TBL] [Abstract][Full Text] [Related]
3. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.
Riera M; Torras J; Herrero I; Valles J; Paubert-Braquet M; Cruzado JM; Alsina J; Grinyo JM
J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292
[TBL] [Abstract][Full Text] [Related]
4. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
[TBL] [Abstract][Full Text] [Related]
5. The role of platelet-activating factor (PAF) antagonists and nitric oxide in cardiac actions of PAF. Electrophysiological and morphological study.
Kecskeméti V; Balogh I
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):723-35. PubMed ID: 11192945
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of platelet activating factor antagonists on cultured endothelial cell lysis induced by elastase or activated neutrophils.
Renesto P; Vicart P; Paulin D; Chignard M
Br J Pharmacol; 1996 Mar; 117(5):902-6. PubMed ID: 8851508
[TBL] [Abstract][Full Text] [Related]
7. Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro.
Hirafuji M; Shinoda H
Br J Pharmacol; 1991 Jun; 103(2):1333-8. PubMed ID: 1884095
[TBL] [Abstract][Full Text] [Related]
8. Interference of WEB 2086 and BN 52021 with Paf-induced effects on guinea-pig trachea.
Brunelleschi S; Renzi D; Ledda F; Giotti A; Fantozzi R; Brink C; Benveniste J
Br J Pharmacol; 1989 Jun; 97(2):469-74. PubMed ID: 2758225
[TBL] [Abstract][Full Text] [Related]
9. Effect of PAF antagonists on cerulein-induced pancreatitis.
Jancar S; Abdo EE; Sampietre SN; Kwasniewski FH; Coelho AM; Bonizzia A; Machado MC
J Lipid Mediat Cell Signal; 1995 Jan; 11(1):41-9. PubMed ID: 7537159
[TBL] [Abstract][Full Text] [Related]
10. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists.
Domingo MT; Piro F; Broquet C; Auclair E; Chabrier PE; Braquet P
Lipids; 1992 Aug; 27(8):582-6. PubMed ID: 1328798
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological evidence of a role for platelet activating factor as a modulator of vasomotor tone and blood pressure.
Lopes-Martins R; Catelli M; Araújo C; Estato V; Cordeiro R; Tibiriçá E
Eur J Pharmacol; 1996 Jul; 308(3):287-94. PubMed ID: 8858301
[TBL] [Abstract][Full Text] [Related]
12. Involvement of platelet-activating factor in the modulation of vascular tone in the isolated perfused rabbit kidney.
Cailleaux S; Lopes-Martins RA; Aimbire F; Cordeiro RS; Tibiriçá E
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):505-11. PubMed ID: 10431763
[TBL] [Abstract][Full Text] [Related]
13. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets.
Robaut C; Durand G; James C; Lave D; Sedivy P; Floch A; Mondot S; Pacot D; Cavero I; Le Fur G
Biochem Pharmacol; 1987 Oct; 36(19):3221-9. PubMed ID: 2822048
[TBL] [Abstract][Full Text] [Related]
14. Endothelium-dependent vasodilation in the isolated rabbit kidney following in vivo and in vitro ischaemia and reperfusion: effects of antagonizing platelet activating factor (PAF).
Uluoglu C; Timlioglu O
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):324-30. PubMed ID: 10543435
[TBL] [Abstract][Full Text] [Related]
15. Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist.
Bagnis C; Deray G; Dubois M; Pirotzky E; Jacquiaud C; Baghos W; Aupetit B; Braquet P; Jacobs C
Nephrol Dial Transplant; 1996 Mar; 11(3):507-13. PubMed ID: 8671822
[TBL] [Abstract][Full Text] [Related]
16. [Platelet-activating factor (PAF) antagonists].
Terasawa M
Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
[No Abstract] [Full Text] [Related]
17. PAF-receptor. 1. 'Cache-oreilles' effect of selected high-potency platelet-activating factor (PAF) antagonists.
Dive G; Godfroid JJ; Lamotte-Brasseur J; Batt JP; Heymans F; Dupont L; Braquet P
J Lipid Mediat; 1989; 1(4):201-15. PubMed ID: 2562434
[TBL] [Abstract][Full Text] [Related]
18. Effect of platelet-activating factor on porcine pulmonary blood vessels in vitro.
Pritze S; Simmet T; Peskar BA
Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):495-9. PubMed ID: 1766475
[TBL] [Abstract][Full Text] [Related]
19. Cell adhesion by membrane-bound paf-acether.
Ninio E; Leyravaud S; Bidault J; Jurgens P; Benveniste J
Int Immunol; 1991 Nov; 3(11):1157-63. PubMed ID: 1760410
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats.
Teather LA; Magnusson JE; Wurtman RJ
Psychopharmacology (Berl); 2002 Oct; 163(3-4):430-3. PubMed ID: 12373444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
